"A new class of anti-obesity drugs that suppresses appetite by blocking cannabinoid receptors in the brain could also suppress the adaptive rewiring of the brain necessary for neural development in children, studies with mice have indicated. One such drug, rimonabant (trade name Acomplia) has been developed by Sanofi-Aventis and is awaiting approval for use in the U.S., and other pharmaceutical companies are developing similar drugs."As if they should not always use "caution" with any drug and for anyone.
An Oprah threat to your health and the health of your children? Have you been misled?
Find out at www.Oprahcide.com or www.DeathByOprah.com
See FTC complaints about Oprah and her diet experts at www.JailForOprah.com
Saturday, May 17, 2008
Caution Recommended For New Anti-Obesity Drug In Children
Oops.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment